Nasdaq Technology

Analysts on Wall Street project that BigCommerce (BIGC) will announce quarterly earnings of $0.05 per share in its forthcoming report, representing an increase of 150% year over year. Revenues are projected to reach $81.4 million,

Analysts on Wall Street project that Envestnet (ENV) will announce quarterly earnings of $0.53 per share in its forthcoming report, representing an increase of 17.8% year over year. Revenues are projected to reach $312.24 million,

Wall Street analysts expect United Therapeutics (UTHR) to post quarterly earnings of $3.92 per share in its upcoming report, which indicates a year-over-year increase of 46.8%. Revenues are expected to be $561.77 million, up 14.3%

The upcoming report from Insulet (PODD) is expected to reveal quarterly earnings of $0.67 per share, indicating an increase of 21.8% compared to the year-ago period. Analysts forecast revenues of $460.17 million, representing an i

In its upcoming report, American Homes 4 Rent (AMH) is predicted by Wall Street analysts to post quarterly earnings of $0.42 per share, reflecting an increase of 5% compared to the same period last year. Revenues are forecasted to

In its upcoming report, Outfront Media (OUT) is predicted by Wall Street analysts to post quarterly earnings of $0.64 per share, reflecting an increase of 14.3% compared to the same period last year. Revenues are forecasted to be

Wall Street analysts expect Ryman Hospitality Properties (RHP) to post quarterly earnings of $1.94 per share in its upcoming report, which indicates no change from the year-ago quarter. Revenues are expected to be $623.86 million,

The upcoming report from Travel + Leisure Co. (TNL) is expected to reveal quarterly earnings of $1.37 per share, indicating an increase of 5.4% compared to the year-ago period. Analysts forecast revenues of $940.86 million, repres

Tech stocks fell late Friday afternoon with the Technology Select Sector SPDR Fund (XLK) decreasing 0.9% and the SPDR S&P Semiconductor ETF (XSD) down 1.6%.

Royalty Pharma (RPRX) reported $736 million in revenue for the quarter ended December 2023, representing a year-over-year decline of 30.8%. EPS of $1.15 for the same period compares to $1.56 a year ago.

American Axle & Manufacturing (AXL) reported $1.46 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 5.1%. EPS of -$0.09 for the same period compares to -$0.07 a year ago.

For the quarter ended December 2023, Vulcan Materials (VMC) reported revenue of $1.83 billion, up 5.9% over the same period last year. EPS came in at $1.46, compared to $1.08 in the year-ago quarter.

Telephone & Data Systems (TDS) reported $1.31 billion in revenue for the quarter ended December 2023, representing a year-over-year decline of 3.2%. EPS of -$0.11 for the same period compares to -$0.38 a year ago.

Healthcare Realty Trust (HR) reported $330.44 million in revenue for the quarter ended December 2023, representing a year-over-year decline of 2.3%. EPS of $0.39 for the same period compares to -$0.09 a year ago.

Appian (APPN) reported $145.32 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 15.5%. EPS of $0.06 for the same period compares to -$0.28 a year ago.

For the quarter ended December 2023, Cinemark Holdings (CNK) reported revenue of $638.9 million, up 6.5% over the same period last year. EPS came in at -$0.15, compared to -$0.82 in the year-ago quarter.

For the quarter ended December 2023, United States Cellular (USM) reported revenue of $1 billion, down 4.6% over the same period last year. EPS came in at $0.16, compared to -$0.33 in the year-ago quarter.

For the quarter ended December 2023, Barnes Group (B) reported revenue of $415.54 million, up 32.6% over the same period last year. EPS came in at $0.41, compared to $0.52 in the year-ago quarter.

Arbor Realty Trust (ABR) reported $331.06 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 3.3%. EPS of $0.51 for the same period compares to $0.60 a year ago.

Blueprint Medicines (BPMC) reported $71.96 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 85.6%. EPS of -$1.82 for the same period compares to -$2.65 a year ago.